For carnitine-acylcarnitine translocase (CACT) deficiency and MTPD patients with fever, cardiac monitoring was specifically recommended based on the clinical experience of the workshop participants with increased risk of cardiomyopathy in these patients during acute illness. This evidence concerns the gene SLC25A20 and cardiomyopathy.